Superworth

Electromed price to free cash flow ELMD

Market value divided by free cash flow over the last twelve months, since 2013.

Today, Oct 23, 2026
26.2×
10-year median
29.3×
Against its 10-year history
37th
percentile: 0 is its lowest day, 100 its highest
10-year range
12.8× to 237×
Peer median
12.8×

Electromed's price to free cash flow is 26.2× as of Oct 23, 2026.

That is below its ten-year median of 29.3×, close to the middle of its last ten years.

Over that time it ranged from 12.8× in Aug 2025 to 237× in Nov 2016.

The median for 10 healthcare stocks of a similar size is 12.8×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far26.2×23.4×40.4×
202527.1×12.8×28.4×
202421.7×16.9×73.7×
202375.0×70.4×75.0×
2022145×91.9×150×
202194.2×21.7×94.2×
202021.5×20.7×74.3×
201960.8×20.7×70.6×
201821.4×20.9×29.0×
201724.2×21.2×214×
2016204×7.9×237×
20159.2×6.0×15.8×
201415.2×8.4×15.2×
20135.3×5.3×15.7×

Against its peers

Companies in Healthcare nearest Electromed's size, closest first, today.

CompanyPrice to free cash flow
ELMDElectromed26.2×
NATRNatures Sunshine Products11.8×
UTMDUtah Medical Products20.6×
PLXProtalix BioTherapeutics26.8×
PDEXPro DEX29.5×
INFUInfuSystem12.1×
VMDViemed Healthcare12.8×
EMBCEmbecta2.3×
ARVNArvinasn/m
NRCNRC Health22.4×
KEQUKewaunee Scientific8.7×
Peer median12.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Electromed

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.